Daratumumab with bortezomib, lenalidomide and dexamethasone for untreated multiple myeloma when a stem cell transplant is suitable TA1195 30 September 2026 30 September 2026 Isatuximab with ...
All NICE products on prostate cancer. Includes any guidance, advice and quality standards.
Evidence-based recommendation on trastuzumab deruxtecan (Enhertu) for treating HER2-low metastatic or unresectable breast cancer after chemotherapy in adults. This guidance updates and replaces NICE ...
This guideline has been updated and replaced by epilepsies in children, young people and adults ...
Evidence Documents containing the evidence that was used to develop the recommendations. Supporting evidence Surveillance report 2024 exceptional surveillance of familial breast cancer: classification ...
This guidance has been updated and replaced by NICE technology appraisal guidance on pembrolizumab with pemetrexed and platinum chemotherapy for untreated ...
Evidence-based recommendations on trastuzumab deruxtecan (Enhertu) for treating HER2-positive unresectable or metastatic breast cancer after 1 or more anti-HER2 treatments in adults. Next review: More ...
intermittently scanned continuous glucose monitoring. HCL systems are only recommended if they are procured at a cost-effective price agreed by the companies and NHS England, and implemented following ...
Evidence-based recommendations on lusutrombopag (Mulpleo) for treating severe thrombocytopenia in adults with chronic liver disease needing a planned invasive procedure. The scope for this multiple ...
An aligned pathway between the Medicines and Healthcare products Regulatory Agency (MHRA) and NICE, along with an improved advice service, will help bring medicines to patients faster and give ...
This guideline covers nutrition and weight management in pregnancy for anyone who may become pregnant, is planning to become pregnant or is already pregnant, and nutrition in children up to 5 years.
This guideline has been updated and replaced by NICE's guideline on pneumonia in adults: diagnosis and management (NG250).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results